• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchOliPass
    Picture of OliPass logo

    244460 — OliPass Share News

    KR₩1,6510.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
    • Enterprise Value
    • Revenue
      KR₩816m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 244460 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    244460 Dividends
    • Brief: Olipass To Acquire Real Estate Worth 72 Billion Won

      27/05/2024 02:39
    • Brief: Olipass To Conduct Capital Increase Of 6.5 Billion Won

      19/12/2023 01:46
    • Brief: Olipass To Conduct Capital Increase Of 5 Billion Won For Operational Funds

      04/09/2023 12:07
    • Brief: Vanda Pharmaceuticals And OliPass Announce Strategic Partnership To Develop Antisense Oligonucleotide Therapeutics

      29/09/2022 21:30
    • Brief: Olipass Corp SCN9A Antisense Pain Killer OLP-1002 Moves Into Phase 2A Stage

      25/10/2021 13:40

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.